SANGAMO THERAPEUTICS, INCSGMO

Market cap

$139.73M

P/E ratio

	Dec 31, 2011	Dec 31, 2012	Dec 31, 2013	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023
Revenues	10	22	24	46	40	19	37	84	102	118	111	111	176
Research and development	32	32	37	57	67	66	66	115	146	181	231	250	234
General and administrative	14	12	14	16	19	26	27	47	62	67	63	63	61
Total operating expenses	46	44	51	73	86	92	93	162	208	248	294	313	450
Goodwill and Intangible Asset Impairment	-	-	-	-	-	-	-	-	-	-	-	-	89
Impairment of long-lived assets	-	-	-	-	-	-	-	-	-	-	-	-	66
Total operating expenses	46	44	51	73	86	92	93	162	208	248	294	313	450
Loss from operations	-36	-22	-27	-27	-47	-73	-56	-77	-105	-130	-183	-201	-274
Interest and Other Income	-	-	-	-	-	-	2	8	10	9	5	9	11
Loss before income taxes	-	-	-	-	-46	-72	-55	-69	-95	-121	-178	-192	-263
Income tax (benefit) expense	-	-	-	-	-6	-0	-	-	-	0	0	0	-5
Net loss	-	-	-	-	-	-	-	-69	-95	-121	-178	-192	-258
Net loss attributable to non-controlling interest	-	-	-	-	-	-	-	-1	-0	-0	-0	-	-
Net loss attributable to Sangamo Therapeutics, Inc. stockholders	-36	-22	-27	-26	-41	-72	-55	-68	-95	-121	-178	-192	-258
Earnings Per Share, Basic	-	-	-	-	-	-	-	-	-	-	-1.23	-1.25	-1.48
Earnings Per Share, Diluted	-	-	-	-	-	-	-	-	-	-	-1.23	-1.25	-1.48